Dopamine D2 receptor agonists inhibit lung cancer...

Molecular Oncology 2015 / 01 Vol. 9; Iss. 1

Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells

Hoeppner, Luke H., Wang, Ying, Sharma, Anil, Javeed, Naureen, Van Keulen, Virginia P., Wang, Enfeng, Yang, Ping, Roden, Anja C., Peikert, Tobias, Molina, Julian R., Mukhopadhyay, Debabrata
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Language:
english
Journal:
Molecular Oncology
DOI:
10.1016/j.molonc.2014.08.008
Date:
January, 2015
File:
PDF, 3.58 MB
english, 2015
Conversion to is in progress
Conversion to is failed